Liver Cancer Stage B (Intermediate, BCLC-B)
Reviewed by Oncology Team, VICI Healthcare | Last updated: 2026-04
What Stage B (Intermediate, BCLC-B) Means
>3 nodules or nodule >5 cm, no vascular invasion, PS 0–1
Treatment Approach for Stage B (Intermediate, BCLC-B)
TACE, sequential TACE + sorafenib. Lenvatinib emerging option. Consider atezolizumab+bevacizumab. Palliative intent.
Survival Rates and Prognosis
The 5-year survival rate for liver cancer at Stage B (Intermediate, BCLC-B) is approximately 5-year: 30–50%. Survival rates are statistical averages drawn from large patient populations and may not reflect your individual outcome. Factors that influence your specific prognosis include your age, overall health, tumour biology, and how well the cancer responds to treatment.
Important: These numbers are drawn from historical data. Newer treatments available today may improve outcomes beyond what published statistics show. Discuss your individual prognosis with your oncologist.
How Other Stages Compare
| Stage | 5-Year Survival | Treatment |
|---|---|---|
| Stage 0 (Very early, BCLC-0) | 5-year: 70–80% | Resection, ablation (RFA/MWA), or transplant. Adjuvant therapy per protocol…. |
| Stage A (Early, BCLC-A) | 5-year: 50–70% | Resection, ablation, TACE, or transplant. Consider adjuvant therapy. Curative… |
| Stage C (Advanced, BCLC-C) | 5-year: 10–20% | Sorafenib, lenvatinib, atezolizumab+bevacizumab. Clinical trials. Immunotherapy… |
| Stage D (Terminal, BCLC-D) | 5-year: <5% | Best supportive care, palliative care focus. Consider clinical trials if… |
Liver Cancer Treatment in Top Cities
Liver Cancer in Gurgaon
Liver Cancer in Noida
Liver Cancer in Mumbai
Liver Cancer in Bangalore
Liver Cancer in Hyderabad
Liver Cancer in Chennai
Liver Cancer in Kolkata
Diagnosed with Stage B (Intermediate, BCLC-B) Liver Cancer?
Our specialists can review your reports and create a personalised treatment plan.